As part of the Rare Disease Master Class Science & Tech Innovation track from the 2023 RARE Advocacy Summit, this session shows when and how to bring the patient voice into the discussion when communicating with regulatory authorities, and how to avoid missteps in the research process that
are costly in terms of both time and money.
7 Ways to Engage the FDA
Moderator:
Lea Ann Browning-McNee, MS
Director of Communications and Stakeholder Engagement, Reagan-Udall Foundation
Panelists:
* Mark Dant
Founder, Ryan Foundation
* Kari Rosbeck
President and CEO, TSC Alliance
* Patti Engel, RN, BSN
President and CEO, Engage Health
Stay Connected
Sign up for updates straight to your inbox.